Corpus ID: 6526326

Cancer Biology and Signal Transduction Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer

@inproceedings{Brand2014CancerBA,
  title={Cancer Biology and Signal Transduction Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer},
  author={T. Brand and M. Iida and E. F. Dunn and Neha Luthar and Kellie T. Kostopoulos and Kelsey L Corrigan and Matthew J Wleklinski and D. Yang and K. Wisinski and R. Salgia and D. L. Wheeler},
  year={2014}
}
  • T. Brand, M. Iida, +8 authors D. L. Wheeler
  • Published 2014
  • Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e., estrogen receptor–negative, progesterone receptor–negative, and HER2-negative) that have poor prognosis and very few identified molecular targets. Strikingly, a high percentage of TNBCs overexpresses the EGF receptor (EGFR), yet EGFR inhibition has yielded little clinical benefit. Over the last decade, advances in EGFR biology have established that EGFR functions in two distinct signaling pathways: (i) classical… CONTINUE READING

    Figures from this paper

    References

    SHOWING 1-10 OF 42 REFERENCES
    Role of epidermal growth factor receptor in breast cancer
    • 190
    Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells*
    • 148
    • PDF
    Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer.
    • 268
    Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.
    • 267
    • PDF
    Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
    • 89
    • PDF
    Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.
    • 195
    Src: a potential target for the treatment of triple-negative breast cancer.
    • 108
    The nuclear epidermal growth factor receptor signaling network and its role in cancer.
    • 181
    Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis
    • 76
    • PDF
    Nuclear EGFR contributes to acquired resistance to cetuximab
    • 265
    • PDF